Legal & General Group PLC Theravance Biopharma, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 63,222 shares of TBPH stock, worth $613,885. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,222

Previous 63,222 -0.0%

Holding current value

$613,885

Previous $509,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $89,556 - $107,165	10,803 Added 20.61%	63,222 $536,000
Q1 2024 May 14, 2024	BUY	$8.22 - $11.59 $16,645 - $23,469	2,025 Added 4.02%	52,419 $470,000
Q4 2023 Feb 15, 2024	SELL	$8.58 - $11.4 $42,788 - $56,851	-4,987 Reduced 9.0%	50,394 $566,000
Q3 2023 Nov 14, 2023	SELL	$8.38 - $10.44 $15,209 - $18,948	-1,815 Reduced 3.17%	55,381 $477,000
Q2 2023 Aug 14, 2023	BUY	$10.16 - $11.92 $4,074 - $4,779	401 Added 0.71%	57,196 $591,000
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $13,857 - $16,061	1,404 Added 2.53%	56,795 $616,000
Q4 2022 Feb 14, 2023	SELL	$9.65 - $11.34 $4,516 - $5,307	-468 Reduced 0.84%	55,391 $621,000
Q3 2022 Nov 14, 2022	SELL	$8.39 - $10.22 $25,547 - $31,119	-3,045 Reduced 5.17%	55,859 $566,000
Q2 2022 Aug 22, 2022	BUY	$8.41 - $10.34 $12,749 - $15,675	1,516 Added 2.64%	58,904 $534,000
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $74 - $116	-9 Reduced 0.02%	57,388 $549,000
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $108,688 - $161,860	14,648 Added 34.27%	57,397 $634,000
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $75,986 - $161,737	11,224 Added 35.6%	42,749 $316,000
Q2 2021 Aug 12, 2021	BUY	$14.52 - $22.46 $6,693 - $10,354	461 Added 1.48%	31,525 $458,000
Q1 2021 May 17, 2021	SELL	$16.57 - $21.08 $3,330 - $4,237	-201 Reduced 0.64%	31,064 $634,000
Q3 2020 Nov 13, 2020	SELL	$14.79 - $22.49 $32,981 - $50,152	-2,230 Reduced 6.66%	31,265 $463,000
Q2 2020 Aug 14, 2020	SELL	$20.64 - $30.69 $10,175 - $15,130	-493 Reduced 1.45%	33,495 $703,000
Q1 2020 May 14, 2020	BUY	$17.84 - $31.21 $161,416 - $282,388	9,048 Added 36.28%	33,988 $785,000
Q4 2019 Feb 13, 2020	BUY	$16.12 - $25.89 $28,403 - $45,618	1,762 Added 7.6%	24,940 $646,000
Q3 2019 Nov 13, 2019	BUY	$16.51 - $23.78 $39,425 - $56,786	2,388 Added 11.49%	23,178 $452,000
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $7,800 - $12,575	500 Added 2.46%	20,790 $339,000
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $23,608 - $29,444	1,046 Added 5.44%	20,290 $460,000
Q4 2018 Feb 15, 2019	BUY	$22.52 - $35.07 $123,905 - $192,955	5,502 Added 40.04%	19,244 $492,000
Q2 2018 Aug 10, 2018	SELL	$22.06 - $25.52 $25,126 - $29,067	-1,139 Reduced 7.65%	13,742 $312,000
Q1 2018 May 17, 2018	SELL	$23.37 - $29.71 $146,272 - $185,954	-6,259 Reduced 29.61%	14,881 $361,000
Q4 2017 Feb 13, 2018	BUY	$25.82 - $35.66 $545,834 - $753,852	21,140	21,140 $591,000

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $648M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Theravance Biopharma, Inc. Transaction History